Training for Academic Hematology

此申请是在大卫格芬竞争性更新的小灵通机构国家服务奖 加州大学洛杉矶分校医学院，准备研究员在血液学的学术生涯。这份奖赏 2002年7月成立，支持血液学/内科肿瘤学第2年和第3年的4个奖学金名额 训练在已进入该方案的11名研究员中，4名目前正在接受培训，7名已完成培训。 奖学金，其中4人在加州大学洛杉矶分校的全职教师，两人在临床试验开发与工业， 一个已经进入临床实践。学院由31名学术科学家和医生组成， 分为四个领域的共同研究兴趣，造血和干细胞生物学（肯尼思 Dorshkind博士，主任），白血病（加里席勒，医学博士，主任），淋巴细胞生物学和淋巴瘤 (Alan Lichelman，MD，主任）和止血、血栓形成和血管生物学（维克托Marder，MD， 主任）。所有的教师都有校外研究补助金的支持，其中包括24（77%）与NIH赠款。 与互补学科的其他培训计划的互动强调了我们的互动目标 基础和转化研究职业。每年春天都会举行一次研究务虚会，在此期间， 导师介绍了实验室的研究兴趣的概述，然后是各自的报告 伙伴们的进步对指导者的有效性以及学员的进展和目标进行正式审查， 由四位焦点总监组成的指导委员会编写。向所有人提供核心课程 研究员，包括一个“临床研究课程”，其中包括研究设计和分析的主题， 伦理、监管、问题、赠款准备和负责任的研究行为。鼓励研究员 作为星星计划的一部分，获得高级学位， 各部门再延长一到两年。在7名完成项目的研究员中， 2002年至今，2人获得硕士学位，1人获得博士学位。培训 具有基础、临床和转化研究专业知识的血液学家是 大卫格芬医学院在加州大学洛杉矶分校和本申请寻求支持之间的关键时期 临床培训和最终的职业生涯在学术血液学。

This application is for competitive renewal of a PHS Institutional National Service Award at the David Geffen School of Medicine at UCLA to prepare fellows for an academic career in Hematology. This award was nitiated in July, 2002, and supports 4 fellowship slots in years 2 and 3 of Hematology/Medical Oncology training. Of 11 fellows who have entered the program, 4 are currently in training and 7 have completed their fellowship, of which 4 are on the full-time faculty at UCLA, two are in clinical trial development with industry, and one has entered clinical practice. The faculty consists of 31 academic scientists and physicians, grouped into four areas of mutual research interest, Hematopoiesis and Stem Cell Biology (Kenneth Dorshkind, PhD, Director), Leukemia (Gary Schiller, MD, Director), Lymphocyte Biology and Lymphoma (Alan Lichtenstein, MD, Director) and Hemostasis, Thrombosis and Vascular Biology (Victor Marder, MD, Director). All the faculty have extramural research grant support, including 24 (77%) with NIHgrants. Interaction with other training programs in complementary disciplines emphasizes our goal of interactive basic and translational research careers. A research retreat is; held each spring, during which time each mentor presents an overview of the laboratories' research interest, followed by a report of the respective fellows' progress. Formal review of the mentor's effectiveness and the fellow's progress and goals are prepared by the Steering Committee, made up of the four Focus Directors. A core curriculum is offered to all fellows, including a "Clinical Research Course", which covers subjects on research design and analysis, ethics, regulatory,issues, grant preparation and responsible conduct of research. Fellows are encouraged to obtain an advanced degree as part of the STAR program, with formal course work in appropriate departments for one or two additional years. Of the 7 fellows who have completed their program during the interval 2002 - present, 2 have obtained the Master's degree and 1 has received a PhD degree. The training of hematologists with expertise in basic, clinical and translational research is an important priority for the David Geffen School of Medicine at UCLA and this application seeks support for the pivotal period between clinical training and an eventual career in academic hematology.